ESR1 and invasive carcinoma: ER+, oestrogen receptor‐positive; ER−, oestrogen receptor‐negative; ID, patient pseudonym; NAC, neoadjuvant chemotherapy; NST, invasive carcinoma of no special type; PR+, progesterone receptor‐positive; PR−, progesterone receptor‐negative.